Coronavirus (COVID-19)

This page contains medical information for clinicians on the 2019 Novel Coronavirus (COVID-19, also called 2019-nCoV, and now clinically SARS‐CoV‐2). This section includes articles that pertain to clinicians and cardiologists on the virus, new technologies being deployed to fight the virus and clinical information from various sources. Here are direct links for medical professionals to COVID-19 resources from the U.S. Food and Drug Administration (FDA)Centers for Disease Control (CDC) and the World Health Organization (WHO). Daily world-wide statistics on the coronavirus outbreak are available from the WHO Situations Reports. Here is the Centers for Medicare and Medicaid Services (CMS) frequently asked questions and answers (FAQs) for healthcare providers regarding Medicare payment for laboratory tests and other services related to the COVID-19.

News | Coronavirus (COVID-19)

September 8, 2020 - Heart patients hospitalized with COVID-19 (SARS-CoV-2) can safely continue taking angiotensin ...

Home September 08, 2020
Home
News | Coronavirus (COVID-19)

September 3, 2020 — Why so many COVID-19 (SARS-CoV-2) patients get blood clots (thrombosis) remains uncertain. But ...

Home September 03, 2020
Home
Videos | TCT

With COVID-19 forcing all medical conferences to go virtual in 2020, Juan F. Granada, M.D., CEO of the Cardiovascular ...

Home August 01, 2020
Home
News | Left Atrial Appendage (LAA) Occluders

August 21, 2020 — According to a report published by Research Dive, the rising number of patients suffering from atrial ...

Home August 21, 2020
Home
In the era of COVID-19, remote technical assistance has become big deal. GE Healthcare showed its Digital Expert technology at the ASE 2020 virtual meeting, which allows remote one-on-one echo training or ultrasound machine technical assistance. It became an important service for GE since the start of the pandemic. 
Feature | ASE

August 19, 2020 — From point-of-care ultrasound (POCUS) that has been a key technology during the COVID-19 pandemic, to ...

Home August 19, 2020
Home
Blog | Coronavirus (COVID-19)

COVID-19 is creating a new generation of cardiac patients.  With heart disease already the leading cause of deaths ...

Home August 17, 2020
Home
COVID-19 has a big impact on the heart, and patients with pre-existing cardiovascular disease have at least a 10 percent higher risk of death and severe complications due to the virus. The virus also can cause myocarditis, blood clotting, and impact the cardiovascular system due to severe, hyperactive inflammatory responses.  Left, a cardiac CT scan 3-D rendering. right, the COVID-19 virus from a National Institutes of Health (NIH) photo.
Feature | Coronavirus (COVID-19)

August 17, 2020 - The number of people coronavirus disease 2019 (COVID-19) is rising with more cases in the U.S. There ...

Home August 17, 2020
Home
News | Cardiovascular Education | Dave Fornell, Editor

All medical conferences moved to a virtual meeting format due to COVID-19 this year, and there has been apprehension ...

Home August 14, 2020
Home
Videos | CT Angiography (CTA)

Todd Villines, M.D., FACC, FAHA, MSCCT, explains some of the discussion on CT used for COVID-19 patients at the Society ...

Home August 11, 2020
Home
News | Coronavirus (COVID-19)

August 7, 2020 — The National Institutes of Health (NIH) announced research funding to encourage the development of ...

Home August 07, 2020
Home
Abiomed Impella is now authorized to treat critical ICU COVID-19 patients on ECMO who develop pulmonary edema or need cardiac decompensation from myocarditis. #COVID19 #SARScov2 #Impella
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor

August 5, 2020 — The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) this week for ...

Home August 05, 2020
Home
Left, a 3-D rendering of a heart from a cardiac CT exam. Right, a lung-CT exam showing the heart and ground glass lesions in the lungs of a COVID-19 patient. CT has become a front-line imaging modality in the COVID era because it offers both cardiac and lung information to help determine a patients disposition with chest pain, COVID-19 and COVID-caused myocarditis and pulmonary embolism.
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor

July 28, 2020 — The use of cardiovascular computed tomography angiography (CCTA) is one of the areas that has seen a ...

Home July 28, 2020
Home
Videos | EP Lab

Devi G. Nair, M.D., FHRS, director of cardiac electrophysiology, St. Bernards Heart and Vascular Center, Jonesboro, Ark ...

Home July 28, 2020
Home
Figure B — Top panel, neutrophils noted in collections within small vessels (blue arrow), plump endothelial cells (yellow arrowhead) and a single perivascular dying myocyte (blue arrowhead). Bottom panel, single myocyte undergoing degeneration (blue arrowhead) and plump endothelial cell (yellow arrowhead). Figure C — Electron microscopy, showing particles of SARS-CoV-2 virus present within a cardiac endothelial cell (blue arrowheads), but not present in neighboring cardiac myocyte. #COVID19
Feature | Coronavirus (COVID-19)

July 23, 2020 - A series of autopsies conducted by Louisiana State University (LSU) Health New Orleans pathologists ...

Home July 23, 2020
Home
News | Coronavirus (COVID-19)

July 16, 2020 – Frost and Sullivan’s recent analysis, Post-Pandemic Global Healthcare Market Outlook, 2020, forecasts ...

Home July 16, 2020
Home
Subscribe Now